Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Americas COVID-19 Testing Market Outlook (2023 to 2033)

Americas COVID-19 testing market valuation is at US$ 5.1 billion in 2023 and is likely to be valued at US$ 9.8 billion by 2033. The sales of Americas COVID-19 testing are expected to rise at a CAGR of 6.7% during the forecast period.

Detection of Early Virus Increase the Adoption of Americas COVID-19 Testing

The outbreak of COVID-19 waves rapidly spread all around the globe with a high risk of morbidity is estimated to raise the demand for Americas COVID-19 testing.

  • The rising demand for sampling kits due to high mortality risk is increasing the adoption of Americas COVID-19 testing during the forecast period.
  • The growing health concerns among people and the spreading COVID-19 virus drive the market expansion.
  • The rising symptoms such as cough, fever, cold, and body pain are increasing the demand for Americas COVID-19 testing kits.
  • The rising demand for Americas COVID-19 testing kits to detect and reduce the spread of the virus is growing market share.
  • The adoption of Nasopharyngeal swab samples is commonly preferred due to their high availability are growing market size.
  • The popularity of e-commerce and online sales is increasing the adoption of Americas COVID-19 testing in social distancing.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Complications in Americas COVID-19 Testing Decline Market Growth

The rising risk of diagnostic problems in testing is limiting the market growth. In addition, several complications in testing equipment are slowing down the market size.

Launching vaccine doses to control COVID-19 cases may restrain the market growth. In addition, the unavailability of COVID-19 testing may limit the market's growth.

Efforts of Front-line Leaders Increase Market Opportunities

The outbreak of the COVID-19 virus has destroyed human life in the last three years. However, the front-line workers and healthcare experts continue to work overtime to detect diseases and provide vaccination doses, which are rapidly growing market opportunities. In a report by the WHO, in Mar 2020, in the global market, death rates rose up to 18,000. Therefore, normalizing the situation and treating patients are estimated to increase the demand for Americas COVID-19 testing.

Manufacturers are developing diagnostic kits to reduce the spread of the COVID-19 virus from one person to another. The Drug Controller of India approved Diagnostic Kit for doctors to treat COVID-19 patients in recent times.

Attributes Details
Market CAGR (2023 to 2033) 6.7%
Market Valuation (2023) US$ 5.1 billion
Market Valuation (2033) US$ 9.8 billion
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Americas COVID-19 Testing Market 2017 to 2022 Historic Sales Compared to 2023 to 2033 Future Outlook

According to Future Market Insights (FMI), the sales of Americas COVID-19 testing kits are expected to grow at a CAGR of 6.7% during the forecast period. The SARS-Cov-2 virus is highly infectious and can spread at a very high rate. It can cause health concerns such as mild fever, cough, cold, and body aches. If left unchecked, it might even prove fatal.

To detect the virus early and to reduce its spread, it is essential to diagnose the presence of infection in the human body. Furthermore, early detection aids in timely treatment that can help control symptoms and offer better patient care. Therefore, the market grew at a CAGR of 8.4% from 2017 to 2022.

Short Term (2022 to 2025): The rising demand for Americas COVID-19 testing to detect the virus among patients drives the market growth.

Medium Term (2025 to 2028): The rising awareness of health concerns and symptoms is increasing the adoption of Americas COVID-19 testing.

Long Term (2028 to 2032): Sales from eCommerce channels to drive the market during the forecast period.

The market is estimated to reach US$ 9.8 billion during the forecast period. In the historical period, the market stood at a valuation of US$ 4.8 billion from 2017 to 2022.

Comparative Analysis of Adjacent Markets

Americas COVID-19 Testing Market:

Attributes Americas COVID-19 Testing Market
CAGR (2023 to 2033) 6.7%
Value (2023) US$ 5.1 billion
Value (2033) US$ 9.8 billion
Trends The increasing online shopping is expanding the market during the forecast period.
Opportunities The rising awareness of health concerns and symptoms is increasing the adoption of Americas COVID-19 testing

COVID-19 Diagnostics Market:

Attributes COVID-19 Diagnostics Market
CAGR (2023 to 2033) 7.5%
Value (2023) US$ 112.56 billion
Value (2033) US$ 231.99 billion
Trends Rising population, lack of drug and manufacturing diagnostic kits
Opportunities The rising key players, governments regulations, and emerging Start-ups

Software Testing Market:

Attributes Software Testing Market
CAGR (2023 to 2033) 6%
Value (2023) US$ 50.50 billion
Value (2033) US$ 90.44 billion
Trends Rising demand for better cloud systems with minimal error
Opportunities Growing adoption of software testing in healthcare and manufacturing industries

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Top Two Segment in the Market

Segments Test Type
Top Category SARS-CoV2 IgM/IgG Antibody Rapid Test Kits
Historic CAGR 8.2%
Forecast CAGR 6.0%
Segments Sample Type
Top Category Blood
Historic CAGR 7.9%
Forecast CAGR 5.6%

How are SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits Contributing to Revenue Generation?

Based on test type, the market is categorized into SARS-CoV2 IgM/IgG Antibody Rapid Test Kits, SARS-CoV-2 Antigen Rapid Test Kits, and Multiplex Real-time RT-PCR Assay Kits. SARS-CoV-2 IgM/IgG Antibody rapid test kits have a higher potential for growth in the coming years. As a result, the segment is estimated to capture a high CAGR of 6.0% during the forecast period.

Preference for antibody rapid testing kits among healthcare providers promotes the growth of this segment in the long term. Adopting SARS-CoV-2 IgM/IgG Antibody rapid test kits to screen and detect patients' COVID-19 infections is driving market share. As a result, the category secured a CAGR of 8.2% in the historical period from 2017 to 2022.

Blood is the Most Sought-after Category in the Sample Type Segment

The global market is categorized into the blood and nasopharyngeal swabs based on sample type. The blood sample type category dominates the global market by securing a CAGR of 5.6% during the forecast period. Furthermore, collecting blood samples to detect patients' health and bringing out plasma therapy to treat patients significantly increase the demand for blood samples. As a result, the category secured a CAGR of 7.9% in the historical period from 2017 to 2022.

What is the Scope of Growth for Online Sales Channels?

Despite hospital pharmacies leading the market, online sales channels are expected to experience significant growth in the Americas COVID-19 testing market. The online sales channels contribute a CAGR of 6.8% for the duration of the forecast period. The primarily attributed to higher acceptance of online sales and convenience to users along with discounts and offers reducing costs through home deliveries.

Top Countries Data Table Mentioned Below:

Country USA
CAGR (2017 to 2022) 8.1%
CAGR (2023 to 2023) 6.5%
Valuation (2023 to 2033) 3.5 billion
Country United Kingdom
CAGR (2017 to 2022) 7.1%
CAGR (2023 to 2023) 5.8%
Valuation (2023 to 2033) 412.4 million
Country China
CAGR (2017 to 2022) 7.7%
CAGR (2023 to 2023) 6.2%
Valuation (2023 to 2033) 703.2 million
Country Japan
CAGR (2017 to 2022) 6.6%
CAGR (2023 to 2023) 5.3%
Valuation (2023 to 2033) 574.8 million
Country South Korea
CAGR (2017 to 2022) 5.3%
CAGR (2023 to 2023) 4.5%
Valuation (2023 to 2033) 338.1 million

How is the COVID-19 Testing Market Faring in the USA?

During the forecast period, the USA is securing a CAGR of 6.5% with a valuation of US$ 3.5 billion. Research collaborations and license agreements for healthcare products lead the USA market. Recent technological advancements will create opportunities for the development of innovative products. Key players are currently focusing on strategies, including acquisitions and mergers, in addition to new product launches in the region.

For instance, in June 2020, the Novacyt Group announced the launch of three products for Americas COVID-19 testing market. The products are Exsig™ Direct, Exsig™ Mag, i.e. RNA extraction kits, and COVID-HT test, i.e. a high-throughput test for COVID-19. These products are going to support the COVID-19 diagnosis segment of the company. As a result, the USA market secured a CAGR of 8.1% in the historical period from 2017 to 2022.

What Factors are Driving Growth in the United Kingdom?

The United Kingdom market is estimated to secure a CAGR of 5.8% with a valuation of US$ 412.4 million during the forecast period. The rising prevalence of COVID-19 infections and technological advancements in the healthcare sector are key factors that propel the United Kingdom COVID-19 testing market.

Besides this, favorable reimbursement policies of the United Kingdom government continue to create opportunities for market growth during the forecast period. As a result, the United Kingdom market secured a CAGR of 7.1% in the historical period from 2017 to 2022.

What Opportunities will Manufacturers Capitalize for China Market Growth?

China is contributing a CAGR of 6.2% with a valuation of US$ 703.2 million in the global market through the forecast period. Key players in the country mainly focus on expanding their market presence in the Americas. Steps taken by the government in China to contain the virus have been a key growth enabler.

The World Health Organization (WHO) announced the novel coronavirus outbreak as a public health emergency; China actively readied for the pandemic. The Ministry of Health in the country established an Emergency Operations Centre (COE) to prepare the healthcare system to respond actively to a medical emergency.

Substantial progress in actions taken to contain the unprecedented outbreak created attractive prospects for the COVID-19 testing market in the country. The China market secured a CAGR of 7.7% in the historical period from 2017 to 2022.

Competitive Landscape in the Americas COVID-19 Testing Market

Manufacturers in the Americas COVID-19 testing market are primarily aiming at strategic acquisitions, collaborations, and launches of innovative products to cater to the market demand. In addition, production capacity expansion is also likely to gain traction as global demand for testing continues to rise rapidly.

The prominent manufacturers keep their eye on the patient's requirements to launch better testing equipment during the forecast period. Moreover, prominent vendors are setting goals to fight against several COVID-19 variants. At present, the fast-spreading coronavirus variant in other countries is estimated to raise the production of Americas COVID-19 testing by manufacturers.

Some of the leading companies operating in the market are

  • Sky Medical Supplies & Equipment LLC.
  • Sugentech, Inc.
  • Novacyt Group
  • Aurora Instruments Ltd.
  • PRIMA Lab SA
  • SD Biosensor, INC.
  • Gold Standard Diagnostics
  • Eurofins Technologies
  • Biomerieux SA
  • Danaher

Recent Developments in the Americas COVID-19 Testing Market:

  • For instance, Sugentech, Inc. began the distribution of the SGTi-flex COVID-19 IgM/IgG test kit after gaining FDA approval in April 2020.
  • In August 2020, Novacyt Group launched Winterplex&trade, a CE-Mark-approved polymerase chain reaction (PCR) respiratory test panel, which is a real-time PCR detection of multiple viruses.
  • In May 2020, Biomerieux SA announced the launch of the VIDAS anti-SARS-CoV-2 serology tests, which detect the presence of antibodies in the body for SARS-COV-2. The product has received a CE mark.

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ billion for Value
Key Countries Covered USA, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa
Key Segments Covered
  • Test Type
  • Sample Type
  • Distribution Channel
  • Region
Key Companies Profiled
  • Sky Medical Supplies & Equipment LLC.
  • Sugentech, Inc.
  • Novacyt Group
  • Aurora Instruments Ltd.
  • PRIMA Lab SA
  • SD Biosensor, INC.
  • Gold Standard Diagnostics
  • Eurofins Technologies
  • Biomerieux SA
  • Danaher
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Americas COVID-19 Testing Market by Category

By Test Type:

  • SARS-CoV2 IgM/IgG Antibody Rapid Test Kits
  • SARS-CoV-2 Antigen Rapid Test Kits
  • Multiplex Real-time RT-PCR Assay Kits

By Sample Type:

  • Blood
  • Nasopharyngeal Swabs

By Distribution Channel:

  • Hospital Pharmacies
  • Diagnostic Laboratories
  • Retail Pharmacies
  • Drug Store
  • Online Sales Channel

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

Frequently Asked Questions

Which Was the Widely Popular COVID-19 Test Type?

SARS-CoV-2 IgM/IgG antibody rapid test kits was the widely popular COVID-19 test type.

How was the Historical Performance of the COVID-19 Testing Market in America?

The United States market recorded a CAGR of 8.1% in 2022.

How was the Historical Performance of the COVID-19 Testing Market in the United Kingdom?

The market recorded a CAGR of 7.1% in 2022.

How was the Historical Performance of the COVID-19 Testing Market in China?

The market recorded a CAGR of 7.7% in 2022.

Who are the Key Americas COVID-19 Testing Market Players?

Sky Medical Supplies & Equipment LLC., Sugentech, Inc., and Novacyt Group are key Americas COVID-19 testing market players.

Table of Content

1. Executive Summary | Americas COVID-19 Testing Market

    1.1. Americas Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Test Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Test Type, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Test Type, 2023 to 2033

        5.3.1. SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits

        5.3.2. SARS-CoV-2 Antigen Rapid Test Kits

        5.3.3. Multiplex Real-Time RT-PCR Assay Kits

    5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033

6. Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Sample Type, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Sample Type, 2023 to 2033

        6.3.1. Blood

        6.3.2. Nasopharyngeal Swabs

    6.4. Y-o-Y Growth Trend Analysis By Sample Type, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Sample Type, 2023 to 2033

7. Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Distribution Channel, 2017 to 2022

    7.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033

        7.3.1. Hospital Pharmacies

        7.3.2. Diagnostic Laboratories

        7.3.3. Retail Pharmacies

        7.3.4. Drug Store

        7.3.5. Online Sales Channels

    7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033

8. Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2017 to 2022

    8.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Test Type

        9.2.3. By Sample Type

        9.2.4. By Distribution Channel

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Test Type

        9.3.3. By Sample Type

        9.3.4. By Distribution Channel

    9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Argentina

        10.2.2. By Test Type

        10.2.3. By Sample Type

        10.2.4. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Test Type

        10.3.3. By Sample Type

        10.3.4. By Distribution Channel

    10.4. Key Takeaways

11. Key Countries Market Analysis

    11.1. USA

        11.1.1. Pricing Analysis

        11.1.2. Market Share Analysis, 2022

            11.1.2.1. By Test Type

            11.1.2.2. By Sample Type

            11.1.2.3. By Distribution Channel

    11.2. Canada

        11.2.1. Pricing Analysis

        11.2.2. Market Share Analysis, 2022

            11.2.2.1. By Test Type

            11.2.2.2. By Sample Type

            11.2.2.3. By Distribution Channel

    11.3. Brazil

        11.3.1. Pricing Analysis

        11.3.2. Market Share Analysis, 2022

            11.3.2.1. By Test Type

            11.3.2.2. By Sample Type

            11.3.2.3. By Distribution Channel

    11.4. Mexico

        11.4.1. Pricing Analysis

        11.4.2. Market Share Analysis, 2022

            11.4.2.1. By Test Type

            11.4.2.2. By Sample Type

            11.4.2.3. By Distribution Channel

    11.5. Argentina

        11.5.1. Pricing Analysis

        11.5.2. Market Share Analysis, 2022

            11.5.2.1. By Test Type

            11.5.2.2. By Sample Type

            11.5.2.3. By Distribution Channel

12. Market Structure Analysis

    12.1. Competition Dashboard

    12.2. Competition Benchmarking

    12.3. Market Share Analysis of Top Players

        12.3.1. By Regional

        12.3.2. By Test Type

        12.3.3. By Sample Type

        12.3.4. By Distribution Channel

13. Competition Analysis

    13.1. Competition Deep Dive

        13.1.1. Sky Medical Supplies & Equipment LLC.

            13.1.1.1. Overview

            13.1.1.2. Product Portfolio

            13.1.1.3. Profitability by Market Segments

            13.1.1.4. Sales Footprint

            13.1.1.5. Strategy Overview

                13.1.1.5.1. Marketing Strategy

                13.1.1.5.2. Product Strategy

                13.1.1.5.3. Channel Strategy

        13.1.2. Sugentech, Inc.

            13.1.2.1. Overview

            13.1.2.2. Product Portfolio

            13.1.2.3. Profitability by Market Segments

            13.1.2.4. Sales Footprint

            13.1.2.5. Strategy Overview

                13.1.2.5.1. Marketing Strategy

                13.1.2.5.2. Product Strategy

                13.1.2.5.3. Channel Strategy

        13.1.3. Novacyt Group

            13.1.3.1. Overview

            13.1.3.2. Product Portfolio

            13.1.3.3. Profitability by Market Segments

            13.1.3.4. Sales Footprint

            13.1.3.5. Strategy Overview

                13.1.3.5.1. Marketing Strategy

                13.1.3.5.2. Product Strategy

                13.1.3.5.3. Channel Strategy

        13.1.4. Aurora Instruments Ltd.

            13.1.4.1. Overview

            13.1.4.2. Product Portfolio

            13.1.4.3. Profitability by Market Segments

            13.1.4.4. Sales Footprint

            13.1.4.5. Strategy Overview

                13.1.4.5.1. Marketing Strategy

                13.1.4.5.2. Product Strategy

                13.1.4.5.3. Channel Strategy

        13.1.5. PRIMA Lab SA

            13.1.5.1. Overview

            13.1.5.2. Product Portfolio

            13.1.5.3. Profitability by Market Segments

            13.1.5.4. Sales Footprint

            13.1.5.5. Strategy Overview

                13.1.5.5.1. Marketing Strategy

                13.1.5.5.2. Product Strategy

                13.1.5.5.3. Channel Strategy

        13.1.6. SD Biosensor, INC.

            13.1.6.1. Overview

            13.1.6.2. Product Portfolio

            13.1.6.3. Profitability by Market Segments

            13.1.6.4. Sales Footprint

            13.1.6.5. Strategy Overview

                13.1.6.5.1. Marketing Strategy

                13.1.6.5.2. Product Strategy

                13.1.6.5.3. Channel Strategy

        13.1.7. Gold Standard Diagnostics

            13.1.7.1. Overview

            13.1.7.2. Product Portfolio

            13.1.7.3. Profitability by Market Segments

            13.1.7.4. Sales Footprint

            13.1.7.5. Strategy Overview

                13.1.7.5.1. Marketing Strategy

                13.1.7.5.2. Product Strategy

                13.1.7.5.3. Channel Strategy

        13.1.8. Eurofins Technologies

            13.1.8.1. Overview

            13.1.8.2. Product Portfolio

            13.1.8.3. Profitability by Market Segments

            13.1.8.4. Sales Footprint

            13.1.8.5. Strategy Overview

                13.1.8.5.1. Marketing Strategy

                13.1.8.5.2. Product Strategy

                13.1.8.5.3. Channel Strategy

        13.1.9. Biomerieux SA

            13.1.9.1. Overview

            13.1.9.2. Product Portfolio

            13.1.9.3. Profitability by Market Segments

            13.1.9.4. Sales Footprint

            13.1.9.5. Strategy Overview

                13.1.9.5.1. Marketing Strategy

                13.1.9.5.2. Product Strategy

                13.1.9.5.3. Channel Strategy

        13.1.10. Danaher

            13.1.10.1. Overview

            13.1.10.2. Product Portfolio

            13.1.10.3. Profitability by Market Segments

            13.1.10.4. Sales Footprint

            13.1.10.5. Strategy Overview

                13.1.10.5.1. Marketing Strategy

                13.1.10.5.2. Product Strategy

                13.1.10.5.3. Channel Strategy

14. Assumptions & Acronyms Used

15. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Market Value (US$ million) Forecast by Region, 2017 to 2033

Table 2: Market Volume (Units) Forecast by Region, 2017 to 2033

Table 3: Market Value (US$ million) Forecast by Test Type, 2017 to 2033

Table 4: Market Volume (Units) Forecast by Test Type, 2017 to 2033

Table 5: Market Value (US$ million) Forecast by Sample Type, 2017 to 2033

Table 6: Market Volume (Units) Forecast by Sample Type, 2017 to 2033

Table 7: Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Table 8: Market Volume (Units) Forecast by Distribution Channel, 2017 to 2033

Table 9: North America Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 10: North America Market Volume (Units) Forecast by Country, 2017 to 2033

Table 11: North America Market Value (US$ million) Forecast by Test Type, 2017 to 2033

Table 12: North America Market Volume (Units) Forecast by Test Type, 2017 to 2033

Table 13: North America Market Value (US$ million) Forecast by Sample Type, 2017 to 2033

Table 14: North America Market Volume (Units) Forecast by Sample Type, 2017 to 2033

Table 15: North America Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Table 16: North America Market Volume (Units) Forecast by Distribution Channel, 2017 to 2033

Table 17: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 18: Latin America Market Volume (Units) Forecast by Country, 2017 to 2033

Table 19: Latin America Market Value (US$ million) Forecast by Test Type, 2017 to 2033

Table 20: Latin America Market Volume (Units) Forecast by Test Type, 2017 to 2033

Table 21: Latin America Market Value (US$ million) Forecast by Sample Type, 2017 to 2033

Table 22: Latin America Market Volume (Units) Forecast by Sample Type, 2017 to 2033

Table 23: Latin America Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Table 24: Latin America Market Volume (Units) Forecast by Distribution Channel, 2017 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Market Value (US$ million) by Test Type, 2023 to 2033

Figure 2: Market Value (US$ million) by Sample Type, 2023 to 2033

Figure 3: Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 4: Market Value (US$ million) by Region, 2023 to 2033

Figure 5: Market Value (US$ million) Analysis by Region, 2017 to 2033

Figure 6: Market Volume (Units) Analysis by Region, 2017 to 2033

Figure 7: Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 8: Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 9: Market Value (US$ million) Analysis by Test Type, 2017 to 2033

Figure 10: Market Volume (Units) Analysis by Test Type, 2017 to 2033

Figure 11: Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033

Figure 12: Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033

Figure 13: Market Value (US$ million) Analysis by Sample Type, 2017 to 2033

Figure 14: Market Volume (Units) Analysis by Sample Type, 2017 to 2033

Figure 15: Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 16: Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 17: Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 18: Market Volume (Units) Analysis by Distribution Channel, 2017 to 2033

Figure 19: Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 20: Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 21: Market Attractiveness by Test Type, 2023 to 2033

Figure 22: Market Attractiveness by Sample Type, 2023 to 2033

Figure 23: Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 24: Market Attractiveness by Region, 2023 to 2033

Figure 25: North America Market Value (US$ million) by Test Type, 2023 to 2033

Figure 26: North America Market Value (US$ million) by Sample Type, 2023 to 2033

Figure 27: North America Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 28: North America Market Value (US$ million) by Country, 2023 to 2033

Figure 29: North America Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 30: North America Market Volume (Units) Analysis by Country, 2017 to 2033

Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 33: North America Market Value (US$ million) Analysis by Test Type, 2017 to 2033

Figure 34: North America Market Volume (Units) Analysis by Test Type, 2017 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033

Figure 37: North America Market Value (US$ million) Analysis by Sample Type, 2017 to 2033

Figure 38: North America Market Volume (Units) Analysis by Sample Type, 2017 to 2033

Figure 39: North America Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 40: North America Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 41: North America Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 42: North America Market Volume (Units) Analysis by Distribution Channel, 2017 to 2033

Figure 43: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 44: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 45: North America Market Attractiveness by Test Type, 2023 to 2033

Figure 46: North America Market Attractiveness by Sample Type, 2023 to 2033

Figure 47: North America Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 48: North America Market Attractiveness by Country, 2023 to 2033

Figure 49: Latin America Market Value (US$ million) by Test Type, 2023 to 2033

Figure 50: Latin America Market Value (US$ million) by Sample Type, 2023 to 2033

Figure 51: Latin America Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 52: Latin America Market Value (US$ million) by Country, 2023 to 2033

Figure 53: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 54: Latin America Market Volume (Units) Analysis by Country, 2017 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 57: Latin America Market Value (US$ million) Analysis by Test Type, 2017 to 2033

Figure 58: Latin America Market Volume (Units) Analysis by Test Type, 2017 to 2033

Figure 59: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033

Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033

Figure 61: Latin America Market Value (US$ million) Analysis by Sample Type, 2017 to 2033

Figure 62: Latin America Market Volume (Units) Analysis by Sample Type, 2017 to 2033

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 65: Latin America Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 66: Latin America Market Volume (Units) Analysis by Distribution Channel, 2017 to 2033

Figure 67: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 68: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 69: Latin America Market Attractiveness by Test Type, 2023 to 2033

Figure 70: Latin America Market Attractiveness by Sample Type, 2023 to 2033

Figure 71: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 72: Latin America Market Attractiveness by Country, 2023 to 2033

Recommendations

Industrial Automation

Americas Steel Pipes Market

Published : March 2023

Healthcare

Covid-19 Diagnostics Market

Published : August 2020

Explore Healthcare Insights

View Reports

Americas COVID-19 Testing Market